CD276 and colorectal carcinoma: In a study involving 805 CRC patients, Lu and colleagues identified weak B7-H3 staining in 30.9% (249 out of 805) of the cases, medium staining in 12.4% (100 out of 805), and strong staining in 7.6% (61 out of 805) [67].